Literature DB >> 1757340

Oxygen radical mechanisms of brain injury following ischemia and reperfusion.

R J Traystman1, J R Kirsch, R C Koehler.   

Abstract

This review addresses current understanding of oxygen radical mechanisms as they relate to the brain during ischemia and reperfusion. The mechanism for radical production remains speculative in large part because of the difficulty of measuring radical species in vivo. Breakdown of lipid membranes during ischemia leads to accumulation of free fatty acids. Decreased energy stores during ischemia result in the accumulation of adenine nucleotides. During reperfusion, metabolism of free fatty acids via the cyclooxygenase pathway and metabolism of adenine nucleotides via the xanthine oxidase pathway are the most likely sources of oxygen radicals. Although leukocytes have been found to accumulate in some models of ischemia and reperfusion, their mechanistic role remains in question. Therapeutic strategies aimed at decreasing brain injury have included administration of radical scavengers at the time of reperfusion. Efficacy of traditional oxygen radical scavengers such as superoxide dismutase and catalase may be limited by their inability to cross the blood-brain barrier. Lipid-soluble antioxidants appear more efficacious because of their ability to cross the blood-brain barrier and because of their presence in membrane structures where peroxidative reactions can be halted.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1757340     DOI: 10.1152/jappl.1991.71.4.1185

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  94 in total

Review 1.  Reoxygenation injury of human brain capillary endothelial cells.

Authors:  T Nagashima; S Wu; M Yamaguchi; N Tamaki
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

2.  [Analysis of risk factors and comparison of heparin and hemodilution therapies for retinal artery occlusion].

Authors:  F Rüfer; A Schröder; R Winter; C Erb
Journal:  Ophthalmologe       Date:  2003-10       Impact factor: 1.059

3.  The time course of malondialdehyde production following impact injury to rat spinal cord as measured by microdialysis and high pressure liquid chromatography.

Authors:  H Qian; D Liu
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

4.  Glial damage after transient focal cerebral ischemia in rats.

Authors:  Shunsuke Matsuda; Masahiro Umeda; Hiroyuki Kato; Tsutomu Araki
Journal:  J Mol Neurosci       Date:  2008-12-03       Impact factor: 3.444

Review 5.  The roles of free radicals in amyotrophic lateral sclerosis.

Authors:  D Liu
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

Review 6.  Cerebral vascular dysregulation in the ischemic brain.

Authors:  Alexander Kunz; Costantino Iadecola
Journal:  Handb Clin Neurol       Date:  2009

7.  Comparative studies on dicholesteroyl diselenide and diphenyl diselenide as antioxidant agents and their effect on the activities of Na+/K+ ATPase and delta-aminolevulinic acid dehydratase in the rat brain.

Authors:  Ige J Kade; Marcio W Paixão; Oscar E D Rodrigues; Nilda B V Barbosa; Antonio L Braga; Daiana S Avila; Cristina W Nogueira; João B T Rocha
Journal:  Neurochem Res       Date:  2007-08-21       Impact factor: 3.996

8.  Salidroside-Mediated Neuroprotection is Associated with Induction of Early Growth Response Genes (Egrs) Across a Wide Therapeutic Window.

Authors:  Wenfang Lai; Zhenwei Zheng; Xiaoqin Zhang; Yicong Wei; Kedan Chu; John Brown; Guizhu Hong; Lidian Chen
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

Review 9.  Neuropathophysiology of Brain Injury.

Authors:  Nidia Quillinan; Paco S Herson; Richard J Traystman
Journal:  Anesthesiol Clin       Date:  2016-09

10.  The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia.

Authors:  Sunghee Cho; Eun-Mi Park; Maria Febbraio; Josef Anrather; Laibaik Park; Gianfranco Racchumi; Roy L Silverstein; Costantino Iadecola
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.